RecruitingNCT07175935

Amyotrophic Lateral Sclerosis Registry in Thailand

A Prospective, Multicenter Registry Study of Amyotrophic Lateral Sclerosis in Thailand


Sponsor

Chulalongkorn University

Enrollment

100 participants

Start Date

Mar 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across Thailand. The registry will establish a national dataset to describe epidemiology, clinical presentation, progression, and treatment outcomes, and will serve as a platform for future clinical and translational research.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with als (amyotrophic lateral sclerosis). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

King Chulalongkorn Memorial hospital, The Thai Red Cross Society

Pathum Wan, Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07175935


Related Trials